MENU
FHTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Foghorn Therapeutics (FHTX) Ownership - Who owns Foghorn Therapeutics?

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system... Show more

Profile

Industry
N/A
Address
99 Coolidge Avenue
Phone
+1 617 586-3100
Employees
106
Web
https://www.foghorntx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
121.15M
P/E Ratio
-2.06
Total Cash
167.58M
Projected Growth
N/A
Total Debt
43.1M
Revenue
36.74M
Risk (Beta)
3.64
Dividend Yield
N/A
Total Cash/Share
2.82
Total Debt/Equity
N/A
Revenue/Share
0.55 USD as % of share price
Who owns Foghorn Therapeutics? FHTX symbol Ownership - Tickeron.com